Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Vicky Hsu

1PUBLICATIONS

14CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 01, 2024

FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation.

Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan

Pageof 1

Frequent Collaborators

1 joint publications

Gulsum E Pamuk

1 joint publications

Edwin C Y Chow

1 joint publications

Alexei C Ionan

1 joint publications

Haiyan Chen

1 joint publications

Shwu-Luan Lee

1 joint publications

Manuela Grimstein

1 joint publications

Nan Zheng

1 joint publications

Jielin Sun

1 joint publications

Rosane Charlab

1 joint publications

Brenda J Gehrke

Frequent Collaborators

1 joint publications

Gulsum E Pamuk

1 joint publications

Edwin C Y Chow

1 joint publications

Alexei C Ionan

1 joint publications

Haiyan Chen

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos